Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that the Company ...

India, March 22 -- Researchers at Great Ormond Street Hospital and University College London have successfully engineered a ...

It's rare that a film adaptation outshines its source material but science fiction has given us several remarkable examples ...

Engineered tissue could eventually be used for children born with gaps in their alimentary canal, or for adults whose muscles ...

Humacyte, Inc. (NASDAQ:HUMA) is one of the 11 Best High Volume Penny Stocks to Buy Now. On March 17, 2026, Humacyte, Inc.

Net proceeds from the offering will fund the commercialization of Symvess® in the vascular trauma indication and provide funding beyond key ...

(Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that it has received a minimum ...

While artificial intelligence continues to outperform our human abilities in many areas, Pablo Peña believes critical thinking and curiosity are what will keep us in the driver’s seat. Peña is an ...

Humacyte is also pursuing a mechanism for making Symvess available in Israel on a hospital-by-hospital basis in advance of MAA approval - - Preparation is underway for expansion ...

American researchers have developed artificial lungs and successfully transplanted them into pigs. These bioengineered lungs could potentially be a beacon of hope for the many ...

Biomaterials are specifically engineered to support tissue, nerve and muscle regeneration across the body, yet physicians and ...

Biomaterials are taking medicine by storm – explore some recent preclinical advances in the field that may yield therapeutic benefits.